A proposal for staging COVID‐19 coagulopathy
Authors:
- Jecko ThachilJTJecko Thachil
- Pantep AngchaisuksiriPAPantep Angchaisuksiri
Open Access
- 11 May 2020
- journal article
- research article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 4 (5) , 731-736
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Thromboinflammation and the hypercoagulability of COVID‐19Journal of Thrombosis and Haemostasis, 2022
- Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasisJournal of Thrombosis and Haemostasis, 2020
- Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)JAMA Cardiology, 2020
- Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19Journal of Thrombosis and Haemostasis, 2020
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpJACC, 2020
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Biomarkers of endothelial activation/dysfunction in infectious diseasesVirulence, 2013
- Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging techniqueHaematologica, 2012